
Breakthrough ALS Gene Therapy Launches in the Chinese Mainland
Biogen launches Tofersen, a breakthrough gene-targeted drug for ALS in the Chinese mainland, targeting SOD1 mutations and offering new hope.
Stay informed, stay connected—news for amigos everywhere.
Biogen launches Tofersen, a breakthrough gene-targeted drug for ALS in the Chinese mainland, targeting SOD1 mutations and offering new hope.
The Chinese mainland witnesses a healthcare revolution in Tianjin as it welcomes its first fully foreign-owned general hospital, complementing domestic medical services.